- Home
- LAZR vs ENTA Comparison
LAZR vs ENTA Comparison
Compare LAZR & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAZR
- ENTA
- Stock Information
- Founded
- LAZR 2012
- ENTA 1995
- Country
- LAZR United States
- ENTA United States
- Employees
- LAZR N/A
- ENTA N/A
- Industry
- LAZR Auto Parts:O.E.M.
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- LAZR Consumer Discretionary
- ENTA Health Care
- Exchange
- LAZR Nasdaq
- ENTA Nasdaq
- Market Cap
- LAZR 140.7M
- ENTA 164.6M
- IPO Year
- LAZR N/A
- ENTA 2013
- Fundamental
- Price
- LAZR $3.13
- ENTA $7.52
- Analyst Decision
- LAZR Hold
- ENTA Buy
- Analyst Count
- LAZR 7
- ENTA 5
- Target Price
- LAZR $37.83
- ENTA $18.40
- AVG Volume (30 Days)
- LAZR 4.1M
- ENTA 173.3K
- Earning Date
- LAZR 08-12-2025
- ENTA 08-08-2025
- Dividend Yield
- LAZR N/A
- ENTA N/A
- EPS Growth
- LAZR N/A
- ENTA N/A
- EPS
- LAZR N/A
- ENTA N/A
- Revenue
- LAZR $73,313,000.00
- ENTA $64,462,999.00
- Revenue This Year
- LAZR $16.78
- ENTA N/A
- Revenue Next Year
- LAZR $29.92
- ENTA $2.75
- P/E Ratio
- LAZR N/A
- ENTA N/A
- Revenue Growth
- LAZR N/A
- ENTA N/A
- 52 Week Low
- LAZR $2.52
- ENTA $4.09
- 52 Week High
- LAZR $26.70
- ENTA $15.92
- Technical
- Relative Strength Index (RSI)
- LAZR 48.83
- ENTA 51.19
- Support Level
- LAZR $3.05
- ENTA $7.15
- Resistance Level
- LAZR $3.56
- ENTA $8.31
- Average True Range (ATR)
- LAZR 0.32
- ENTA 0.48
- MACD
- LAZR 0.02
- ENTA 0.01
- Stochastic Oscillator
- LAZR 35.79
- ENTA 55.73
About LAZR Luminar Technologies Inc.
Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and Advanced Technologies and Services. The majority of its revenue is generated from the Autonomy Solutions segment, which engages in the design, manufacturing, and sale of LiDAR sensors, catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries. The Advanced Technologies and Services segment provides semiconductors and related components, as well as design, test, and consulting services to the Autonomy Solutions segment and various third-party customers. Geographically, the company derives its key revenue from North America.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.